Senti Biosciences (SNTI) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.22, -14.16% vs the prior close of $0.26.
- Volume 3.44M shares, 3.5x its 50-day average (heavy).
- New SEC filings: 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
SNTI slides 14.2% to $0.22, a 52-week low on 3.5x normal volume. Closed at $0.22, -14.16% vs the prior close of $0.26. Day range $0.21β$0.25, opened at $0.25.
SNTI daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β SNTI slides 14.2% to $0.22, a 52-week low on 3.5x normal volume
- Closed at $0.22, -14.16% vs the prior close of $0.26. Day range $0.21β$0.25, opened at $0.25.
- Volume was 3.44M shares, 3.5x its 50-day average of 976.80K β unusually heavy trading.
- Price is -33.8% vs its 50-day average ($0.34) and -70.8% vs its 200-day average ($0.77).
- 52-week range $0.21β$2.88; today's close sits at 0% of that range, 92.2% below the 52-week high.
Oct 15, 2026 β SNTI jumps 8.7% to $0.26 on 28.3x normal volume
- Closed at $0.26, +8.71% vs the prior close of $0.24. Day range $0.24β$0.26, opened at $0.24.
- Volume was 16.97M shares, 28.3x its 50-day average of 598.46K β unusually heavy trading.
- Price is -23.4% vs its 50-day average ($0.34) and -66.1% vs its 200-day average ($0.77).
- 52-week range $0.24β$2.88; today's close sits at 1% of that range, 90.9% below the 52-week high.
- SEC filings that day: 8-K.
Oct 14, 2026 β SNTI slides 5.5% to $0.24, a 52-week low
- Closed at $0.24, -5.49% vs the prior close of $0.25. Day range $0.24β$0.26, opened at $0.25.
- Volume was 166.30K shares, 0.3x its 50-day average of 598.27K β lighter than usual.
- Price is -30.0% vs its 50-day average ($0.34) and -69.0% vs its 200-day average ($0.78).
- 52-week range $0.24β$2.88; today's close sits at 0% of that range, 91.6% below the 52-week high.
Oct 13, 2026 β SNTI slides 20.1% to $0.25, a 52-week low
- Closed at $0.25, -20.06% vs the prior close of $0.32. Day range $0.25β$0.31, opened at $0.31.
- Volume was 302.80K shares, 0.5x its 50-day average of 594.96K β lighter than usual.
- Price is -26.6% vs its 50-day average ($0.35) and -67.4% vs its 200-day average ($0.78).
- 52-week range $0.25β$2.88; today's close sits at 0% of that range, 91.1% below the 52-week high.
- SEC filings that day: 8-K.
Oct 12, 2026 β SNTI rises 1.6% to $0.32
- Closed at $0.32, +1.59% vs the prior close of $0.31. Day range $0.31β$0.32, opened at $0.31.
- Volume was 142.70K shares, 0.2x its 50-day average of 595.24K β lighter than usual.
- Price is -8.7% vs its 50-day average ($0.35) and -59.4% vs its 200-day average ($0.79).
- 52-week range $0.29β$2.88; today's close sits at 1% of that range, 88.9% below the 52-week high.
Oct 9, 2026 β SNTI dips 2.5% to $0.31
- Closed at $0.31, -2.48% vs the prior close of $0.32. Day range $0.31β$0.32, opened at $0.32.
- Volume was 109.90K shares, 0.2x its 50-day average of 595.71K β lighter than usual.
- Price is -10.3% vs its 50-day average ($0.35) and -60.3% vs its 200-day average ($0.79).
- 52-week range $0.29β$2.88; today's close sits at 1% of that range, 89.1% below the 52-week high.
Oct 8, 2026 β SNTI dips 2.4% to $0.32
- Closed at $0.32, -2.42% vs the prior close of $0.33. Day range $0.31β$0.33, opened at $0.31.
- Volume was 247.20K shares, 0.4x its 50-day average of 595.35K β lighter than usual.
- Price is -8.2% vs its 50-day average ($0.35) and -59.5% vs its 200-day average ($0.79).
- 52-week range $0.29β$2.88; today's close sits at 1% of that range, 88.8% below the 52-week high.
Oct 7, 2026 β SNTI rises 2.2% to $0.33
- Closed at $0.33, +2.17% vs the prior close of $0.32. Day range $0.31β$0.35, opened at $0.31.
- Volume was 330.70K shares, 0.6x its 50-day average of 591.86K β lighter than usual.
- Price is -6.1% vs its 50-day average ($0.35) and -58.7% vs its 200-day average ($0.80).
- 52-week range $0.29β$2.88; today's close sits at 2% of that range, 88.5% below the 52-week high.
Oct 6, 2026 β SNTI slides 6.4% to $0.32
- Closed at $0.32, -6.38% vs the prior close of $0.34. Day range $0.31β$0.34, opened at $0.32.
- Volume was 204.00K shares, 0.3x its 50-day average of 598.97K β lighter than usual.
- Price is -8.4% vs its 50-day average ($0.35) and -59.8% vs its 200-day average ($0.80).
- 52-week range $0.29β$2.88; today's close sits at 1% of that range, 88.8% below the 52-week high.
Oct 5, 2026 β SNTI jumps 7.1% to $0.34, a 1-month high
- Closed at $0.34, +7.14% vs the prior close of $0.32. Day range $0.31β$0.34, opened at $0.31.
- Volume was 378.30K shares, 0.6x its 50-day average of 595.21K.
- Price is -2.4% vs its 50-day average ($0.35) and -57.3% vs its 200-day average ($0.81).
- 52-week range $0.29β$2.88; today's close sits at 2% of that range, 88.0% below the 52-week high.
Oct 2, 2026 β SNTI dips 0.6% to $0.32
- Closed at $0.32, -0.62% vs the prior close of $0.32. Day range $0.31β$0.33, opened at $0.31.
- Volume was 124.60K shares, 0.2x its 50-day average of 595.06K β lighter than usual.
- Price is -9.2% vs its 50-day average ($0.35) and -60.4% vs its 200-day average ($0.81).
- 52-week range $0.29β$2.88; today's close sits at 1% of that range, 88.8% below the 52-week high.
SNTI latest news & SEC filings
Every SEC filing by or about SNTI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.07 β Reported shareholder vote results.
Oct 13, 2026 Β· Form DEFA14A β Additional proxy materials
Additional proxy materials
Oct 13, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Sep 24, 2026 Β· Form EFFECT β EFFECT filing
EFFECT filing
Sep 24, 2026 Β· Form DEFM14A β DEFM14A filing
DEFM14A filing
Sep 24, 2026 Β· Form 424B3 β Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 24, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Sep 24, 2026 Β· Form PRER14A β PRER14A filing
PRER14A filing
Sep 22, 2026 Β· Form S-3/A β S-3/A filing
S-3/A filing
Sep 11, 2026 Β· Form SCHEDULE 13D/A β Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 10, 2026 Β· Form S-3/A β S-3/A filing
S-3/A filing
Sep 4, 2026 Β· Form PRER14A β PRER14A filing
PRER14A filing
Sep 4, 2026 Β· Form DEFA14A β Additional proxy materials
Additional proxy materials
Sep 4, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 2.03 β Took on a new material debt or financial obligation.
Sep 2, 2026 Β· Form DEFA14A β Additional proxy materials
Additional proxy materials
Things to know before you trade SNTI
- Last results release: Jul 15, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 27, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Oct 14, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.02% (largest 20.1%). That is a volatile stock.
- Liquidity: about 1.99M shares (β$448.11K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.22 vs a range of $0.21β$2.88 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 15, 2026; 8-K Oct 13, 2026; 8-K Sep 24, 2026.
- Share count: 31.14M shares outstanding (Jul 31, 2026), +19.1% vs a year earlier β notable dilution.
- Listing: Nasdaq Β· industry: Biological Products, (No Diagnostic Substances).
SNTI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.25 | 0.25 | 0.21 | 0.22 | 3.44M |
| Oct 15, 2026 | 0.24 | 0.26 | 0.24 | 0.26 | 18.99M |
| Oct 14, 2026 | 0.25 | 0.26 | 0.24 | 0.24 | 166.30K |
| Oct 13, 2026 | 0.31 | 0.31 | 0.25 | 0.25 | 302.80K |
| Oct 12, 2026 | 0.31 | 0.32 | 0.31 | 0.32 | 142.70K |
| Oct 9, 2026 | 0.32 | 0.32 | 0.31 | 0.31 | 109.90K |
| Oct 8, 2026 | 0.31 | 0.33 | 0.31 | 0.32 | 247.20K |
| Oct 7, 2026 | 0.31 | 0.35 | 0.31 | 0.33 | 330.70K |
| Oct 6, 2026 | 0.32 | 0.34 | 0.31 | 0.32 | 204.00K |
| Oct 5, 2026 | 0.31 | 0.34 | 0.31 | 0.34 | 378.30K |
| Oct 2, 2026 | 0.31 | 0.33 | 0.31 | 0.32 | 124.60K |
| Oct 1, 2026 | 0.31 | 0.34 | 0.30 | 0.32 | 613.20K |
| Sep 30, 2026 | 0.30 | 0.32 | 0.30 | 0.31 | 83.60K |
| Sep 29, 2026 | 0.31 | 0.34 | 0.30 | 0.31 | 291.80K |
| Sep 28, 2026 | 0.33 | 0.34 | 0.31 | 0.31 | 549.00K |
| Sep 25, 2026 | 0.32 | 0.34 | 0.31 | 0.33 | 920.50K |
| Sep 24, 2026 | 0.35 | 0.37 | 0.33 | 0.34 | 2.30M |
| Sep 23, 2026 | 0.33 | 0.36 | 0.32 | 0.34 | 10.37M |
| Sep 22, 2026 | 0.31 | 0.34 | 0.31 | 0.32 | 184.10K |
| Sep 21, 2026 | 0.32 | 0.32 | 0.31 | 0.31 | 103.60K |
About Senti Biosciences
Senti Biosciences (SNTI) is listed on the Nasdaq and classified by the SEC under βBiological Products, (No Diagnostic Substances)β. Its business address is in SOUTH SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1854270.
SNTI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Timothy K Lu | CEO | Mar 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Timothy K Lu | CEO | Mar 11, 2026 |
| Kanya Rajangam | Pres. & Chief Med. & Dev. Off. | Mar 11, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
SNTI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $22.00K | $-61.44M | -2.73 | $-43.44M |
| Dec 31, 2024 | $0 | $-52.79M | -12.03 | $-41.40M |
| Dec 31, 2023 | $1.98M | $-71.06M | -16.01 | $-52.40M |
| Dec 31, 2022 | $3.29M | $-58.21M | -2.23 | $-34.90M |
| Dec 31, 2021 | $2.29M | $-55.32M | -19.00 | $-34.63M |
Latest balance sheet: total assets $33.10M, total liabilities $36.51M, cash $6.46M (as of Jun 30, 2026).
SNTI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 15, 2026 | 8-K Item 2.02 (results) | $0.58 |
| May 14, 2026 | 8-K Item 2.02 (results) | $1.04 |
| Mar 27, 2026 | 8-K Item 2.02 (results) | $0.79 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $1.79 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $1.54 |
| May 6, 2025 | 8-K Item 2.02 (results) | $3.30 |
| Apr 28, 2025 | 8-K Item 2.02 (results) | $3.64 |
| Mar 20, 2025 | 8-K Item 2.02 (results) | $3.51 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $2.33 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | β |
| May 9, 2024 | 8-K Item 2.02 (results) | β |
| Mar 21, 2024 | 8-K Item 2.02 (results) | β |
Related stocks Β· Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SNTI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.